+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nephropathy Drug"

IgA Nephropathy (IgAN) - Pipeline Insight, 2024 - Product Thumbnail Image

IgA Nephropathy (IgAN) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Diabetic Nephropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Nephropathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032 - Product Thumbnail Image

IgA Nephropathy (IgAN) - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 100 Pages
  • Global
From
From
From
From
From
From
Diabetic Nephropathy - Epidemiology Forecast to 2032 - Product Thumbnail Image

Diabetic Nephropathy - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
IGA Nephropathy Disease Treatment Market - Forecast 2021 to 2026 - Product Thumbnail Image

IGA Nephropathy Disease Treatment Market - Forecast 2021 to 2026

  • Report
  • January 2022
  • 122 Pages
  • Global
From
From
From
From
From
From
From
Diabetic Nephropathy Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Diabetic Nephropathy Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • March 2020
  • 404 Pages
  • Global
From
Loading Indicator

The Nephropathy Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat nephropathy, a condition that affects the kidneys and can lead to kidney failure. These drugs are used to reduce inflammation, control blood pressure, and reduce the risk of further damage to the kidneys. They can also be used to treat other conditions such as hypertension, diabetes, and lupus. The Nephropathy Drug market is highly competitive, with many companies offering a variety of treatments. These companies include major pharmaceutical companies such as Pfizer, Merck, and Novartis, as well as smaller companies such as Amgen, AstraZeneca, and Bristol-Myers Squibb. Additionally, there are many generic drug manufacturers that offer lower-cost alternatives to brand-name drugs. Show Less Read more